Table 1 Summary of study participant... | American Society of Hematology

Table 1

Summary of study participant characteristics

Group/patient ID	Age, y	Sex	Viral load, copies/mL	CD4⁺ T-cell count, cells/μL (PB)	RB %CD4 (relative to CD3⁺)
Controllers
1554	53.9	Male	77	823	45.3
1139	46.8	Male	50	518	41.1
1545	48.4	Male	249	625	27.9
1518	47.3	Transgender	75	1507	59.2
1256	44.7	Male	820	597	26.2
1560	41.8	Male	1864	701	29.7
1504	45.8	Male	1957	633	25.7
1198	51.9	Male	50	1311	57.3
1529	47.3	Male	50	1000	65.5
Noncontrollers
1292	38.7	Male	24 644	673	44.5
1246	58.5	Male	32 944	221	18
1515	40.8	Male	15 534	196	8.35
1254	46.4	Transgender	32 236	211	10.8
1217	37.8	Male	16 212	389	14.9
1265	45.6	Intersex	20 420	643	32.2
1259	42.2	Male	56 299	206	19.5
1298	49.8	Male	91 199	208	20.7
1190	48.8	Male	21 523	415	13
1094	41.1	Male	24 734	253	14.2
1080	36.2	Male	33 904	354	22.9

Group/patient ID	Age, y	Sex	Viral load, copies/mL	CD4⁺ T-cell count, cells/μL (PB)	RB %CD4 (relative to CD3⁺)
Controllers
1554	53.9	Male	77	823	45.3
1139	46.8	Male	50	518	41.1
1545	48.4	Male	249	625	27.9
1518	47.3	Transgender	75	1507	59.2
1256	44.7	Male	820	597	26.2
1560	41.8	Male	1864	701	29.7
1504	45.8	Male	1957	633	25.7
1198	51.9	Male	50	1311	57.3
1529	47.3	Male	50	1000	65.5
Noncontrollers
1292	38.7	Male	24 644	673	44.5
1246	58.5	Male	32 944	221	18
1515	40.8	Male	15 534	196	8.35
1254	46.4	Transgender	32 236	211	10.8
1217	37.8	Male	16 212	389	14.9
1265	45.6	Intersex	20 420	643	32.2
1259	42.2	Male	56 299	206	19.5
1298	49.8	Male	91 199	208	20.7
1190	48.8	Male	21 523	415	13
1094	41.1	Male	24 734	253	14.2
1080	36.2	Male	33 904	354	22.9

PB indicates peripheral blood; and RB, rectosigmoid biopsies.